文献速递免疫规划卫生政策与健康促进

法国男男性行为者与人乳头瘤病毒疫苗:低疫苗覆盖率可能源于医生很少主动推荐

Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians.
PubMed 文献 · Vaccine · 2020-01-31

该研究通过匿名在线问卷于2018年10月7日至2019年1月15日调查法国男男性行为者(MSM),共2094人完成(平均年龄35.4±11岁)。结果显示HPV疫苗覆盖率低,仅8.0%接种至少1剂,但接种意愿较高;作者认为低覆盖率更多与临床医生很少主动推荐有关,而非疫苗负面认知。

要点

  • 2094名法国MSM中,8.0%接种至少1剂HPV疫苗,目标年龄组(<27岁)为17.9%。
  • 有家庭医生的1728人中,仅9.9%被医生推荐HPV疫苗;目标年龄组为9.1%。
  • 未接种者中34.4%回答「比较愿意」接种,45.5%回答「非常愿意」接种。

核心结论

  • 法国MSM的HPV疫苗覆盖率低,作者认为这一趋势更多与临床医生很少主动推荐有关,而非疫苗负面认知。

研究设计与样本

  • 匿名在线问卷调查,于2018年10月7日至2019年1月15日通过多种途径发放,包括Facebook®暴露前预防(PrEP)使用者讨论论坛。
  • 共2094名参与者完成问卷,平均年龄35.4±11岁;25.8%处于HPV疫苗推荐目标年龄组;16.1%参与PrEP项目。

主要发现

  • 在1-10分评分中,「支持接种疫苗」中位数为10分,疫苗总体有用性中位数为10分,危害性中位数为2分;62.4%认为HPV疫苗不太危险或完全不危险。
  • 使用PrEP者对疫苗接种总体及HPV疫苗的看法更好。
  • 有家庭医生的1728名参与者中,医生推荐HPV疫苗的比例为9.9%;目标年龄组(<27岁)中为9.1%。
  • 1994人知晓自身HPV疫苗接种状态,其中8.0%接种至少1剂;目标年龄组中为17.9%(该年龄组40名PrEP使用者中为52.2%)。
  • 1935名自述未接种HPV疫苗者中,34.4%回答「比较愿意」接种,45.5%回答「非常愿意」接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In France, the human papilloma (HPV) vaccine is recommended to all female adolescents, and since 2016 to men having sex with men (MSM) under the age of 27. Here, we aimed to explore HPV vaccine coverage in adult MSM living in France. METHODS: We elaborated an anonymous online questionnaire targeting MSM and disseminated it between October 7, 2018 and January 15, 2019 by various means, including a Facebook® discussion forum for pre-exposure prophylaxis (PrEP) users. RESULTS: Overall, 2094 participants completed the questionnaire (mean age 35.4 ± 11 years); 25.8% were in the age class targeted by the HPV vaccine recommendation; 16.1% were in a PrEP program. On a 1-10 scale, they evaluated being "in favor of vaccination" at a median of 10, and general vaccine usefulness and harmfulness at medians of 10 and 2, respectively; 62.4% considered that the HPV vaccine was rather not or not at all dangerous. Those using PrEP had better perceptions of vaccination in general and of the HPV vaccine in particular. For the 1728 participants with a family physician, he/she had proposed the HPV vaccine in 9.9% of cases (9.1% of those in the targeted age class [<27 years]). Overall, 1994 knew their HPV vaccine status; 8.0% had received at least 1 dose of the vaccine, including 17.9% of those in the targeted age class (and 52.2% among the 40 participants in this age group who received PrEP). When the 1935 participants who declared to be unvaccinated against HPV were asked whether they would accept to be vaccinated, 34.4% answered "rather yes" and 45.5% "definitely yes". CONCLUSION: HPV vaccine coverage is low among French MSM. Our results suggest that this trend has more to do with the infrequent proposals made by clinicians than with negative vaccine perceptions.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Petit B, Epaulard O. Men having sex with men and the HPV vaccine in France: A low vaccine coverage that may be due to its infrequent proposal by physicians. Vaccine. 2020. PMID: 32008880. doi:10.1016/j.vaccine.2020.01.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。